Coherus Oncology Inc (CHRS) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 16.22%14.31 | 12.31 | 12.75 | 11.57 | 10.25 |
| Cost Of Revenue | 11.22%4.24 | 3.81 | 4.05 | 3.72 | 3.40 |
9.31%20.95 | 23.10 | - | - | - | |
| Selling, General, and Administrative | 9.31%20.95 | 23.10 | - | - | - |
| Research and Development | 0.47%21.44 | 21.54 | - | - | - |
| Interest Income/Expense | 6.27%2.32 | 2.19 | 2.25 | 2.33 | 2.28 |
| Costs And Expenses | 3.76%46.64 | 48.46 | 58.63 | 55.90 | 55.74 |
| Depreciation and Amortization | 2.16%0.86 | 0.88 | 0.90 | 0.97 | 1.02 |
| Operating Income/Loss | 10.57%-32.33 | -36.15 | -45.88 | -44.33 | -45.49 |
| Income/Loss From Continuing Operations Before Tax | 9.71%-33.35 | -36.94 | -46.35 | -44.52 | -44.86 |
| Income/Loss From Continuing Operations After Tax | 9.71%-33.35 | -36.94 | -46.35 | -44.52 | -44.86 |
| Income/Loss From Discontinued Operations, Net Of Tax | 1,014%12.72 | -1.39 | 8.70 | 8.99 | 342.63 |
46.17%-20.63 | -38.33 | -37.64 | -35.53 | 297.77 | |
| Attributable To Parent | 46.17%-20.63 | -38.33 | -37.64 | -35.53 | 297.77 |
| Basic Average Shares | 13.50%154.82 | 136.40 | 1.09 | 116.23 | 116.08 |
| Diluted Average Shares | 13.50%154.82 | 136.40 | 1.09 | 116.23 | 116.08 |
| Basic Earnings Per Share | 53.57%-0.13 | -0.28 | -0.34 | -0.31 | 2.57 |
| Diluted Earnings Per Share | 53.57%-0.13 | -0.28 | -0.34 | -0.31 | 2.57 |